Recent insights into Fc-mediated effector responses to HIV-1
- PMID: 32675573
- PMCID: PMC7732205
- DOI: 10.1097/COH.0000000000000638
Recent insights into Fc-mediated effector responses to HIV-1
Abstract
Purpose of review: Recent work defining Fc-mediated effector functions for both viral control and protection against infection is summarized and considered along with new strategies to drive robust Fc-mediated responses.
Recent findings: In new human and nonhuman primate (NHP) vaccine trials as well as studies of natural infection, Fc-mediated effector responses have sometimes been observed to correlate with decreased risk of infection or with better clinical outcomes, suggesting a potential role for these responses in HIV-1 prevention and therapy. Recent highlights include use of antibody-dependent cellular cytotoxicity-sensitizing CD4-induced mimetic compounds, novel V1V2 immunogens, passive transfer studies, and vaccine regimens that successfully elicited Fc-mediated responses and were reported to decrease risk of infection in challenge studies in NHPs. Lastly, detailed studies of IgG3 forms of HIV-specific antibodies have reported that both neutralizing and Fc-mediated responses can be increased relative to the more prevalent IgG1 subclass.
Summary: Successful harmonization of neutralizing and Fc-mediated responses may make key contributions to the goal of reducing HIV-1 infection via active and passive vaccination. New studies continue to highlight the importance of Fc-mediated antibody responses as correlates of decreased risk of infection and suggest enhanced phagocytosis is a potential mechanism of reduced risk of infection associated with human IgG3 responses. Results from recent studies may help guide the rational design of therapies and vaccines that aim to specifically leverage antibody effector function.
Conflict of interest statement
Conflicts of interest
The authors report no conflicts of interest.
Figures
Similar articles
-
Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.J Virol. 2017 Sep 12;91(19):e00401-17. doi: 10.1128/JVI.00401-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28490585 Free PMC article.
-
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.J Virol. 2019 May 1;93(10):e02119-18. doi: 10.1128/JVI.02119-18. Print 2019 May 15. J Virol. 2019. PMID: 30842326 Free PMC article.
-
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.J Virol. 2018 May 14;92(11):e02198-17. doi: 10.1128/JVI.02198-17. Print 2018 Jun 1. J Virol. 2018. PMID: 29514914 Free PMC article.
-
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019. Front Immunol. 2019. PMID: 31921207 Free PMC article. Review.
-
Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.Curr HIV Res. 2013 Jul;11(5):354-64. doi: 10.2174/1570162x113116660060. Curr HIV Res. 2013. PMID: 24191940 Review.
Cited by
-
Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1.Front Immunol. 2023 Oct 3;14:1271686. doi: 10.3389/fimmu.2023.1271686. eCollection 2023. Front Immunol. 2023. PMID: 37854587 Free PMC article.
-
Broadly Neutralizing Antibodies for HIV-1 Prevention.Front Immunol. 2021 Jul 20;12:712122. doi: 10.3389/fimmu.2021.712122. eCollection 2021. Front Immunol. 2021. PMID: 34354713 Free PMC article. Review.
-
Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.Elife. 2024 Feb 22;12:RP89395. doi: 10.7554/eLife.89395. Elife. 2024. PMID: 38385642 Free PMC article.
-
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.Front Immunol. 2022 Dec 12;13:1051501. doi: 10.3389/fimmu.2022.1051501. eCollection 2022. Front Immunol. 2022. PMID: 36578481 Free PMC article.
-
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.Retrovirology. 2021 Oct 30;18(1):35. doi: 10.1186/s12977-021-00579-9. Retrovirology. 2021. PMID: 34717659 Free PMC article.
References
-
- Alrubayyi A, Schuetz A, Lal KG, Jongrakthaitae S, Paolino KM, Ake JA, Robb ML, de Souza MS, Michael NL, Paquin-Proulx D, et al.: A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity. J Immunol Methods 2018, 462:74–82. - PubMed
-
- Richardson SI, Crowther C, Mkhize NN, Morris L: Measuring the ability of HIV-specific antibodies to mediate trogocytosis. J Immunol Methods 2018, 463:71–83. - PubMed
-
- Fisher L, Zinter M, Stanfield-Oakley S, Carpp LN, Edwards RW, Denny T, Moodie Z, Laher F, Bekker LG, McElrath MJ, et al.: Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells. Front Immunol 2019, 10:2741. - PMC - PubMed
-
*Detection of HIV-1 vaccine-induced ADCC was improved using NK cells treated with IL-15, which mimics cytokine stimulation in natural infection.
-
- Lisovsky I, Kant S, Tremblay-McLean A, Isitman G, Kiani Z, Dupuy FP, Gilbert L, Bruneau J, Shoukry NH, Lebouche B, et al.: Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC. J Leukoc Biol 2019, 105:551–563. - PMC - PubMed
-
*Study of the role of inhibitory NK receptors in NK cell education leading to ADCC activity.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
